CTI BIOPHARMA CORP - COM (CTIC)

CUSIP: 12648L106

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
54,040,712
Share change
+4,309,203
Total reported value
$78,898,679
Put/Call ratio
52%
Price per share
$1.46
Number of holders
76
Value change
+$5,426,235
Number of buys
25
Number of sells
46

Quarterly Holders Quick Answers

What is CUSIP 12648L106?
CUSIP 12648L106 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q3 2015

As of 30 Sep 2015, CTI BIOPHARMA CORP - COM (CTIC) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,040,712 shares. The largest 10 holders included BVF INC/IL, FMR LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, STATE STREET CORP, NORTHERN TRUST CORP, Candriam Luxembourg S.C.A., Lombard Odier Asset Management (USA) Corp, and DEUTSCHE BANK AG\. This page lists 76 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.